EZH2, namely, the enzymatic subunit of polycomb repressive complex 2 [34,35], has been found to be of great importance in various cancers, including bladder cancer, breast cancer, prostate cancer, and so on [36-38]. This evidence concerns the gene EZH2 and prostate cancer.